
@itrisabeli
🇪🇸Account based in
About this account
- Account based in
- Spain
- Connected via
- Spain App Store
Account-level information from X, not a live location or the device used for a specific post.
Breast surgical oncologist, Head, Breast Unit, Working for better training and equity in surgical oncology. #breastcancer. wordl traveler #ILookLikeASurgeon
Madrid, Spain
Joined March 2014
- Tweets2.2K
- Following308
- Followers877
- Likes1.3K
Join colleagues from across Europe to explore what #INTERACTEUROPE100 has achieved and what comes next
This is more than just a conference. It is a shared commitment to make a difference in cancer care. @EuropeanCancer @itrisabel
europeancancer.org/events/44…
IR retweeted
New @uicc call for grants for implementation research on women’s cancers: uicc.org/what-we-do/member-b… Apply through August 31st.
IR retweeted
Local management of second ipsilateral #breastcancer events after primary breast-conserving therapy: an international Delphi consensus
@TheLancetOncol
#radonc #OncoAlert @OncoAlert
50 days' free access to the article
sciencedirect.com/science/ar…
Congrats!!! Escellent presentations at #ASCO2026 and outstanding discussion @DrJudyBoughey Appropriate patient selection is key to achieving the best outcomes from surgical treatment de-escalation strategies.” happy @itrisabel to participate @EUBREAST
⭐ HER2+ early breast cancer: de-escalation with precision ⭐
An important @OncoAlert exclusive for #ASCO26 with Dr. @JavierCortesMD discussing PHERGain and PHERGain-2. 🚨🎗️
These studies speak to one of the most relevant questions in early HER2+ breast cancer:
Can we safely personalize treatment intensity and reduce chemotherapy exposure in selected patients?
A chemotherapy-free, pCR-guided strategy with dual HER2 blockade is not just about response. It is about smarter treatment selection, less toxicity, preserving quality of life, and moving de-escalation from concept to carefully tested clinical strategy. 🧬🩺
Looking forward to this discussion with the OncoAlert Breast faculty. 🌍🤝
@ElisaAgostinett @to_be_elizabeth @WeOncologists @ErikaHamilton9 @E_de_Azambuja @matteolambe @DrSGraff @hoperugo @BianchiniGP @Icro_Meattini @Lucarecco @GaiaGriguolo @aftimosp @double_whammied @stage4kelly @coffeemommy @itsnot_pink @maryam_lustberg @IBCResearch @kevinpunie @nicolobattisti @raalbany @teamoncology @stolaney1 @LoiSher @SirohiBhawna @chemobrainfog @jamecancerdoc @JaniceTNBCmets @Prof_Nadia_H @paspears88 @MammaMiaMagazin @itrisabel @wearemedsir
#OncoAlert #ASCO26 #BreastCancer #HER2Positive #CancerCare
An OncoAlert Exclusive at #ASCO26
Our OncoAlert #BreastCancer Faculty Dr. Javier Cortes presents the recent results of the PHERGain and PHERGain2 studies presented in Berlin for ESMO Breast.
PHERGain-2 demonstrates that a chemotherapy-free, pCR-guided strategy can achieve high response rates in selected patients with early HER2-positive breast cancer. Dual HER2 blockade produced pCR rates near 60%, enabling treatment personalization, reducing chemotherapy exposure, preserving quality of life, and supporting further de-escalation of therapy in carefully selected patients.
Leads🚨
@ElisaAgostinett
@to_be_elizabeth
@WeOncologists
Senior Faculty
@ErikaHamilton9
@E_de_Azambuja
@matteolambe
@DrSGraff
@hoperugo
@BianchiniGP
Dr. Bidard
@Icro_Meattini
Participating AF
@Lucarecco
@GaiaGriguolo
Ping Faculty
@aftimosp @double_whammied @stage4kelly @coffeemommy @itsnot_pink @maryam_lustberg @IBCResearch @kevinpunie @nicolobattisti @raalbany @teamoncology @stolaney1 @LoiSher @SirohiBhawna @chemobrainfog @jamecancerdoc @JavierCortesMD @JaniceTNBCmets @Prof_Nadia_H @paspears88 @MammaMiaMagazin @itrisabel @wearemedsir
IR retweeted
As we get started with #ASCO26, what better way to brush up with what has happened the last year in #BreastCancer
Presentation 👉 buff.ly/l3G1CGn
Get a 13 minute breakdown on ER+ Metastatic Breast Cancer from OncoAlert Faculty Dr. Erika Hamilton of Sarah Cannon🇺🇸
#BreastCancer
@hoperugo 🇺🇸
@matteolambe 🇮🇹
@Icro_Meattini 🇮🇹
Dr. Roberto Salgado 🇧🇪
@ErikaHamilton9 🇺🇸
@DrSGraff 🇺🇸
@itrisabel 🇪🇸
@ESSOnews
@ElisaAgostinett 🇧🇪
@RebeccaDSing 🇸🇬
@LazarPo31787807 🇷🇸
@aftimosp
@to_be_elizabeth
@GaiaGriguolo
@Lucarecco
Our Partners
@ESGO_society
@ESSOnews
@CancerCareMASCC
@SIOGorg
After a great day with sessions, multidisciplinary meetings, debates #EBCC15 @santpaubcn great place to share impressions about the EBCC @EORTC @europadonna @EUSOMA @HenryKuerer @itrisabel @michailignitiadis @TanjaSpanic
IR retweeted
#EBCC15 is about to begin!
A strong start with Isabel Rubio opening one of the most #multidisciplinary meetings in #breastcancer
Looking forward to insightful discussions, collaboration, and progress for our patients
#OncoAlert
@EORTC_BCG @ESTRO_RT @OncoAlert @EuropaDonnaEUR
IR retweeted
OncoAlert 🚨 Coverage of DAY ONE of #EBCC15
Breast Cancer and Communication: Patient Insights from Serbia Presented by Sara Bojanic
An online survey conducted by Europa Donna Serbia in late 2024 among 810 women diagnosed with breast cancer reveals significant gaps in communication between patients and healthcare professionals in Serbia. Despite respondents being largely well educated, more than half reported receiving only partial information, limited time for discussion, and an incomplete understanding of their diagnosis and treatment options, often prompting them to seek information elsewhere. While the information provided was generally perceived as helpful, many patients felt insufficiently informed and unable to ask questions. The findings highlight an urgent need for clearer, more patient‑centred communication, improved health communication skills among professionals, and stronger patient involvement across the breast cancer care pathway. #BreastCancer
@itrisabel
@JavierCortesMD
@MIgnatiadis
@MichaelGnant
@Icro_Meattini
@matteolambe
@c_sotiriou
@aftimosp
@MOliveira_MD
@CarmenCriscit
@lab_kok
@to_be_elizabeth
@ElisaAgostinett
@Lucarecco
@FernandoOnco
@GaiaGriguolo
@JankovicK
@acampsmalea
@kevinpunie
@CarmineDeA1
@LauBuisseret
IR retweeted
OncoAlert 🚨 Coverage of DAY ONE of #EBCC15
RAPCHEM Study Presented by Dr Fleur Mauritz
A ten-year study shows that tailoring radiotherapy after chemotherapy and surgery to a patient’s individual risk keeps breast cancer recurrence rates very low while potentially reducing side-effects. In 848 patients treated in the Netherlands, radiotherapy was adjusted based on whether cancer remained in the lymph nodes after treatment, allowing some low‑risk patients to receive minimal or no radiotherapy. After a decade of follow‑up, only 2.9% experienced a local or regional recurrence, with similarly low rates across low-, intermediate- and high‑risk groups. The findings suggest that carefully stratifying patients by response to chemotherapy can safely reduce overtreatment and support more personalised breast cancer care. For the final conclusion, we will have to wait for the results of a randomised trial from the USA, which are expected in three years. #BreastCancer
@itrisabel
@JavierCortesMD
@MIgnatiadis
@MichaelGnant
@Icro_Meattini
@matteolambe
@c_sotiriou
@aftimosp
@MOliveira_MD
@CarmenCriscit
@lab_kok
@to_be_elizabeth
@ElisaAgostinett
@Lucarecco
@FernandoOnco
@GaiaGriguolo
@JankovicK
@acampsmalea
@kevinpunie
@CarmineDeA1
@LauBuisseret
IR retweeted
Etienne Brain awarded at #EBCC15 👏
A well-deserved recognition followed by an insightful lecture on one of the most pressing issues in our field: treatment challenges and decision-making in elderly patients with #BreastCancer
@EtienneB66 @OncoAlert
#OncoAlert
A word from our Chair, Prof. @itrisabel
At #EBCC15, this multidisciplinary spirit continues to shape discussions and drive progress in breast cancer care.
Explore the searchable programme here 👉 cm.eortc.org/cmPortal/Search…
@OncoAlert #BreastCancer
IR retweeted
Launch of the SSO Career Catalyst Mentorship Program 2026-2027 cohort. Excited to be a mentor in this program @SocSurgOnc
📢 Late Breaking Abstracts submission for EBCC-15, just a few days left!
Have new and impactful data to share? The submission period is open until 9 February 2026.
👉 Submit here: event.eortc.org/ebcc15/call-…
#EBCC15 #BreastCancer #Research #Abstracts #Oncology
Celebrating World Cancer day!! Evidence based prevention strategies and treatments drives progress to reduce the burden of cancer!!
We are happy to join again the 2026 OncoAlert Colloquium!
With ESSO reps presenting highlights in:
➡️ @itrisabel on #BreastCancer surgery
➡️ Johnn Henry Herrera Kok on lower #GIsurgery
➡️ Marco Inama on upper #GIsurgery
Dear Colleagues
Coming February 2026: The 6th Annual OncoAlert Colloquium 🚨
REGISTER👉 oncoalert.m-pages.com/7I0mwF…
Our Faculty List Keeps on Growing and
As ALWAYS ✅Patients Included
#BreastCancer
@hoperugo🇺🇸
@matteolambe🇮🇹
@Icro_Meattini🇮🇹
Dr. Roberto Salgado 🇧🇪
@ErikaHamilton9 🇺🇸
@DrSGraff 🇺🇸
@itrisabel🇪🇸 @ESSOnews
@ElisaAgostinett 🇧🇪
Dr. Fatima Cardoso 🇵🇹
@LazarPo31787807 🇷🇸
#LungCancer
@GlopesMd🇺🇸
@jillfeldman4 @EGFRResisters🇺🇸
@UmbertoMalapel1 🇮🇹 @isliquidbiopsy
@BRicciutiMD 🇺🇸
@gerryhanna 🇮🇪
@UOzkerim 🇹🇷
GU Oncology
@brian_rini 🇺🇸
@declangmurphy 🇦🇺
@KidneyCancer🇺🇸 @salvolarosa
@APCCC_Lugano🇨🇭
@RenuEapen🇦🇺
@nataliagandur 🇦🇷
@seanmcbride 🇺🇸
@GuardConsortium 🇪🇸
GI Oncology
@BenWestphalen 🇩🇪
@florianlordick 🇩🇪
@NiuSanford 🇺🇸
@realbowtiedoc 🇺🇸
@ARosen380 🇺🇸
@Erman_Akkus 🇹🇷
John Herrera Kok
Melanoma
@DrBetofMDPhD 🇺🇸
Myeloma
@Abdallah81MD 🇺🇸
Our Partners
@ESGO_society @ESSOnews @CancerCareMASCC @SIOGorg
Our Collaborators
APCCC, GU CAST, Uromigos and more
and more to come.......
#OncoAlertAF
@FernandoOnco @to_be_elizabeth @bavilima @GaiaGriguolo @JankovicK @MarioBalsaMD @DrMirallas @GIMedOnc @OscarTahuahua @DrRishabhOnco @Onco_Cifu88 @PaulJiL
IR retweeted
Dear Colleagues
Coming February 2026: The 6th Annual OncoAlert Colloquium 🚨
REGISTER👉 oncoalert.m-pages.com/7I0mwF…
Our Faculty List Keeps on Growing and
As ALWAYS ✅Patients Included
#BreastCancer
@hoperugo🇺🇸
@matteolambe🇮🇹
@Icro_Meattini🇮🇹
Dr. Roberto Salgado 🇧🇪
@ErikaHamilton9 🇺🇸
@DrSGraff 🇺🇸
@itrisabel🇪🇸 @ESSOnews
@ElisaAgostinett 🇧🇪
Dr. Fatima Cardoso 🇵🇹
@LazarPo31787807 🇷🇸
#LungCancer
@GlopesMd🇺🇸
@jillfeldman4 @EGFRResisters🇺🇸
@UmbertoMalapel1 🇮🇹 @isliquidbiopsy
@BRicciutiMD 🇺🇸
@gerryhanna 🇮🇪
@UOzkerim 🇹🇷
GU Oncology
@brian_rini 🇺🇸
@declangmurphy 🇦🇺
@KidneyCancer🇺🇸 @salvolarosa
@APCCC_Lugano🇨🇭
@RenuEapen🇦🇺
@nataliagandur 🇦🇷
@seanmcbride 🇺🇸
@GuardConsortium 🇪🇸
GI Oncology
@BenWestphalen 🇩🇪
@florianlordick 🇩🇪
@NiuSanford 🇺🇸
@realbowtiedoc 🇺🇸
@ARosen380 🇺🇸
@Erman_Akkus 🇹🇷
John Herrera Kok
Melanoma
@DrBetofMDPhD 🇺🇸
Myeloma
@Abdallah81MD 🇺🇸
Our Partners
@ESGO_society @ESSOnews @CancerCareMASCC @SIOGorg
Our Collaborators
APCCC, GU CAST, Uromigos and more
and more to come.......
#OncoAlertAF
@FernandoOnco @to_be_elizabeth @bavilima @GaiaGriguolo @JankovicK @MarioBalsaMD @DrMirallas @GIMedOnc @OscarTahuahua @DrRishabhOnco @Onco_Cifu88 @PaulJiL
IR retweeted
Dear Colleagues
Coming 1⃣st Week of February 2026:
The 6th Annual OncoAlert Colloquium 🚨
REGISTER👉 buff.ly/UDfpkP8
Our Faculty List Keeps on Growing and
As ALWAYS ✅Patients Included
#BreastCancer
@hoperugo🇺🇸
@matteolambe🇮🇹
@Icro_Meattini🇮🇹
Dr. Roberto Salgado 🇧🇪
@ErikaHamilton9 🇺🇸
@DrSGraff 🇺🇸
@E_de_Azambuja 🇧🇪
@itrisabel🇪🇸 ESSO
@ElisaAgostinett 🇧🇪
Dr. Fatima Cardoso 🇵🇹 @ABCGlobalAll
@LazarPo31787807 🇷🇸
#LungCancer
@GlopesMd🇺🇸
@jillfeldman4 @EGFRResisters🇺🇸
@UmbertoMalapel1 🇮🇹 @isliquidbiopsy
@BRicciutiMD 🇺🇸
@UOzkerim 🇹🇷
GU Oncology
@brian_rini @Uromigos🇺🇸
@declangmurphy @gu_onc🇦🇺
@KidneyCancer🇺🇸
@APCCC_Lugano🇨🇭
@RenuEapen🇦🇺
@nataliagandur 🇦🇷
@seanmcbride 🇺🇸
GI Oncology
@BenWestphalen 🇩🇪
@CathyEngMD 🇺🇸
@florianlordick 🇩🇪
@NiuSanford 🇺🇸
@realbowtiedoc 🇺🇸
@ARosen380 🇺🇸
@Erman_Akkus 🇹🇷
Melanoma
@DrBetofMDPhD 🇺🇸
Our Partners
@ESGO_society @ESSOnews @CancerCareMASCC @SIOGorg
Our Collaborators
APCCC, GU CAST, @Uromigos and more
and more to come.......
#OncoAlertAF
@HHorinouchi @FernandoOnco
@ElisaAgostinett @to_be_elizabeth @GaiaGriguolo @MarioBalsaMD @DrMirallas @GIMedOnc @DrRishabhOnco @Onco_Cifu88 @PaulJiL
IR retweeted
A warm round of congratulations to our @OncoAlert #BreastCancer Faculty @stolaney1 🇺🇸 on receiving the @AACR Outstanding Investigator Award for Breast Cancer Research at #SABCS25 !
Beyond Proud!
@matteolambe @aftimosp @E_de_Azambuja @DrSGraff @curijoey @ErikaHamilton9 @double_whammied @stage4kelly @coffeemommy @itsnot_pink @maryam_lustberg @IBCResearch @kevinpunie @raalbany @hoperugo @LoiSher @jamecancerdoc @JavierCortesMD @JaniceTNBCmets @Prof_Nadia_H @paspears88 @MammaMiaMagazin @itrisabel
#OncoAlertAF
@nataliagandur @acampsmalea @BRicciutiMD
@HHorinouchi @FernandoOnco
@ElisaAgostinett @to_be_elizabeth @bavilima @realbowtiedoc @Erman_Akkus @Lucarecco @GaiaGriguolo @JankovicK
@MarioBalsaMD @DrMirallas @GIMedOnc @OscarTahuahua @UOzkerim @DrRishabhOnco @Onco_Cifu88 @PaulJiL @DaisukeKotani @DraMartinezLago
Congratulations to Sara Tolaney, Chief of Breast Oncology @DanaFarber who is being honored by @AACR w/their Outstanding Investigator Award for Breast Cancer Research at #SABCS25
bit.ly/3Y0Qd0h
#EBCC15 unites multidisciplinary teams across Europe to share the latest in research, innovation & education.
A unique chance to learn & collaborate with experts advancing breast cancer care. Follow us to stay informed.
#BreastCancer #Oncology































